Daré Bioscience, Inc.
DARE
$2.04
-$0.04-1.92%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.02M | -4.38M | -5.51M | -4.70M | 12.91M |
| Total Depreciation and Amortization | 460.10K | 158.10K | 6.40K | 9.70K | 15.40K |
| Total Amortization of Deferred Charges | -5.90K | 17.50K | -- | -- | 21.20K |
| Total Other Non-Cash Items | 620.70K | 488.10K | 735.10K | 685.70K | 740.60K |
| Change in Net Operating Assets | -2.48M | -1.76M | 9.99M | -1.92M | -783.20K |
| Cash from Operations | -5.42M | -5.47M | 5.23M | -5.92M | 12.90M |
| Capital Expenditure | 153.40K | -157.30K | -562.80K | 282.30K | -285.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 153.40K | -157.30K | -562.80K | 282.30K | -285.20K |
| Total Debt Issued | -- | -- | 0.00 | 561.70K | -- |
| Total Debt Repaid | -521.30K | -187.20K | -187.20K | -124.80K | -66.80K |
| Issuance of Common Stock | 475.00K | 436.20K | 55.50K | 0.00 | 183.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 2.50K | -2.50K | -300.00 | -400.00 | -800.00 |
| Cash from Financing | -43.80K | 246.60K | -132.00K | 436.40K | 115.40K |
| Foreign Exchange rate Adjustments | 12.90K | 13.10K | -66.20K | 22.90K | 14.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | 0.00 | -- | -- |
| Net Change in Cash | -5.30M | -5.37M | 4.47M | -5.18M | 12.75M |